ApolloMed Q2 revenue $348.2M (+29% YoY); adj. EBITDA $35.8M (+44%); reaffirms FY23 guidance

Astrana Health, Inc.

2023-Q2 EPS reported $0.56 revenue$685,453,000

Revenue $348.2M (+29% YoY); Care Partners revenue $325.2M (+32%); net income $13.2M (+10%).
Adjusted EBITDA $35.8M (+44% YoY); reaffirms FY23 guidance: revenue $1.3-1.5B, Adj. EBITDA $120-160M.
Recent deals: entered agreement to acquire Texas Independent Providers (120+ PCPs); formed partnership with IntraCare (425+ providers) with $25M convertible note.
Tax restatement for 2020-2022 related to intercompany dividends; no impact on revenue, EBITDA, or past/forward periods.
Cash and investments $297.7M; total stockholders' equity $566M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Astrana Health, Inc. reported three and six months ended June 30, 2023 results: revenue $348.2 million, net income $13.2 million. Guidance reaffirmed.

Period: three and six months ended June 30, 2023
Revenue: $348.2 million
Net income: $13.2 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

full-year 2023.” Financial Highlights for Second Quarter Ended June 30, 2023: All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. • Total revenue of $348.2 million, up 29% from $269.7 million • Care Partners revenue of $325.2 million, up 32% from $247.3 million • Net income attributable to ApolloMed of $13.2 million, up 10% from $12.0

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-088428

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.